A role for Ifit2 in restricting west nile virus infection in the brain

Journal of Virology

Volumn 87, Issue 15, 2013, Pages 8363-8371

  Cho, Hyelim ^a   Shrestha, Bimmi ^a   Sen, Ganes ^b   Diamond, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON STIMULATED GENE 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ASSAY; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FIBROBLAST; FLAVIVIRUS INFECTION; GRANULAR CELL; IN VIVO STUDY; INFECTION CONTROL; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPECIES COMPARISON; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS STRAIN; WEST NILE FLAVIVIRUS; WILD TYPE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84880609359     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01097-13     Document Type: Article

References (58)

1. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. 2005. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 11:17-1173.
2. Kleiboeker SB. 2011. West Nile virus, p 761-768. InNriagu JO (ed), Encyclopedia of environmental health. Elsevier, Burlington, MA.
3. Artsob H, Gubler DJ, Enria DA, Morales MA, Pupo M, Bunning ML, Dudley JP. 2009. West Nile virus in the New World: trends in the spread and proliferation of West Nile virus in the Western Hemisphere. Zoonoses Public Health 56:357-369.
4. Guerrero-Sanchez S, Cuevas-Romero S, Nemeth NM, Trujillo-Olivera MTJ, Worwa G, Dupuis A, Brault AC, Kramer LD, Komar N, Estrada-Franco JG. 2011. West Nile virus infection of birds, Mexico. Emerg. Infect.Dis. 17:2245-2252.
5. Omalu BI, Shakir AA, Wang G, Lipkin WI, Wiley CA. 2003. Fatal fulminant pan-meningo-polioencephalitis due to West Nile virus. Brain Pathol. 13:465-472.
6. Armah HB, Wang G, Omalu BI, Tesh RB, Gyure KA, Chute DJ, Smith RD, Dulai P, Vinters HV, Kleinschmidt-DeMasters BK, Wiley CA. 2007. Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol. 17:354-362.
7. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA. 2006. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis. 12:395-402.
8. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BRG, Silverman RH, Gale M, Jr, Diamond MS. 2006. PKR and RNase L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J. Virol. 80:7009-7019.
9. Scherbik SV, Paranjape JM, Stockman BM, Silverman RH, Brinton MA. 2006. RNase L plays a role in the antiviral response to West Nile virus. J. Virol. 80:2987-2999.
10. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485.
11. Jiang D, Weidner JM, Qing M, Pan Guo X-BH, Xu C, Zhang X, Birk A, Chang J, Shi P-Y, Block TM, Guo J-T. 2010. Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84:8332-8341.
12. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P, Diamond MS. 2011. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J. Virol. 85:11557-11566.
13. D'Andrea LD, Regan L. 2003. TPR proteins: the versatile helix. Trends Biochem. Sci. 28:655-662.
14. Terenzi F, Hui DJ, Merrick WC, Sen GC. 2006. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281:34064-34071.
15. Abbas YM, Pichlmair A, Górna MW, Superti-Furga G, Nagar B. 2013. Structural basis for viral 5=-PPP-RNA recognition by human IFIT proteins. Nature 494:60-64.
16. Katibah GE, Lee HJ, Huizar JP, Vogan JM, Alber T, Collins K. 2013. tRNA binding, structure, and localization of the human interferoninduced protein IFIT5. Mol. Cell 49:743-750.
17. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin Schneller T-YS, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB,Pierson TC, Buller RM, Gale M, Jr, Shi P-Y, Diamond MS. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456.
18. Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M, Jr, Virgin HW, Klein RS, Sen GC, Diamond MS. 2012. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and-independent mechanisms of host restriction in vivo. PLoS Pathog. 8:e1002698. doi:10.1371/journal.ppat.1002698.
19. Perwitasari O, Cho H, Diamond MS, Gale M, Jr. 2011. Inhibitor of B kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection. J. Biol. Chem. 286:44412-44423.
20. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8:e1002712. doi:10.1371/journal.ppat.1002712.
21. Li Y, Li C, Xue P, Zhong B, Mao AP, Ran Y, Chen H, Wang Y-Y, Yang F, Shu H-B. 2009. ISG56 is a negative-feedback regulator of virustriggered signaling and cellular antiviral response. Proc. Natl. Acad. Sci.U.S.A. 106:7945-7950.
22. Pichlmair A, Lassnig C, Eberle C-A, Górna MW, Baumann CL, Burkard TR, Bürckstümmer T, Stefanovic A, Krieger S, Bennett KL, Rülicke T, Weber F, Colinge J, Müller M, Superti-Furga G. 2011. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat. Immunol. 12:624-630.
23. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC. 2011. The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286:7257-7266.
24. Ebel GD, Carricaburu J, Young D, Bernard KA, Kramer LD. 2004. Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am. J. Trop. Med. Hyg. 71:493-500.
25. Vogt M.R, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS. 2009. Humanmonoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J. Virol. 83:6494-6507.
26. Zhou Y, Ray D, Zhao Y, Dong H, Ren S, Li Z, Guo Y, Bernard KA, Shi P-Y, Li H. 2007. Structure and function of flavivirus NS5 methyltransferase. J. Virol. 81:3891-3903.
27. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77:2578-2586.
28. Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Jr, Früh K, Diamond MS. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9:e1003118. doi:10 .1371/journal.ppat.1003118.
29. Austin BA, James C, Silverman RH, Carr DJJ. 2005. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J. Immunol. 175:1100-1106.
30. Mehlhop E, Diamond MS. 2006. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 203:1371-1381.
31. Fuchs A, Pinto AK, Schwaeble WJ, Diamond MS. 2011. The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412:101-109.
32. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH ,Hansen TH, Diamond MS. 2007. Antigen-specific cytotoxic Tlymphocytes protect against lethal West Nile virus encephalitis. Eur. J. Immunol. 37:1845-1854.
33. Szretter KJ, Samuel MA, Gilfillan S, Fuchs A, Colonna M, Diamond MS. 2009. The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile virus pathogenesis. J. Virol. 83:9329-9338.
34. Lazear HM, Pinto AK, Vogt MR, Gale M, Jr, Diamond MS. 2011. Beta interferon controls West Nile virus infection and pathogenesis in mice. J. Virol. 85:7186-7194.
35. Klein RS, Lin E, Zhang B, Luster AD, Tollett J, Samuel MA, Engle M, Diamond MS. 2005. Neuronal CXCL10 directs CD8_T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
36. Züst R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, Szretter KJ, Baker SC, Barchet W, Diamond MS, Siddell SG, Ludewig B, Thiel V. 2011. Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12:137-143.
37. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361.
38. Daffis S, Samuel MA, Keller BC, Gale M, Jr, Diamond MS. 2007. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 3:e106. doi:10.1371/journal.ppat.0030106.
39. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M, Jr, Diamond MS. 2008. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 82:8465-8475.
40. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, Rudensky AY, Bevan MJ, Clark EA, Kaja M-K, Diamond MS, Gale M, Jr. 2010. IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog. 6:e1000757. doi:10.1371/journal.ppat.1000757.
41. Berchtold S, Manncke B, Klenk J, Geisel J, Autenrieth IB, Bohn E. 2008. Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol. 9:75.
42. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2007. Protective capacity and epitope specificity of CD8(_) T cells responding to lethal West Nile virus infection. Eur. J. Immunol. 37:1855-1863.
43. Shrestha B, Diamond MS. 2004. Role of CD8_ T cells in control of West Nile virus infection. J. Virol. 78:8312-8321.
44. Wang Y, Lobigs M, Lee E, Müllbacher A. 2003. CD8_ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J. Virol. 77:13323-13334.
45. Shrestha B, Samuel MA, Diamond MS. 2006. CD8_ T cells require perforin to clear West Nile virus from infected neurons. J. Virol. 80:119-129.
46. Terenzi F, White C, Pal S, Williams BRG, Sen GC. 2007. Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81:8656-8665.
47. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BRG. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
48. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-525.
49. Diamond MS, Farzan M. 2013. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13:46-57.
50. Sen GC, Sarkar SN. 2007. The interferon-stimulated genes: targets of direct signaling by interferons, double-stranded RNA, and viruses. Curr.Top. Microbiol. Immunol. 3:233-250.
51. Wacher C, Müller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, Terenzi F, Sen GC, King NJC, Campbell IL. 2007. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81:860-871.
52. Zhang Y, Burke CW, Ryman KD, Klimstra WB. 2007. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81:11246-11255.
53. Fitzgerald KA. 2011. The interferon inducible gene: viperin. J. Interferon Cytokine Res. 31:131-135.
54. Hinnebusch AG. 2006. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem. Sci. 31:553-562.
55. Brinton MA. 2002. The molecular biology of West Nile virus: a new invader of the Western Hemisphere. Annu. Rev. Microbiol. 56:371-402.
56. Dong H, Chang DC, Xie X, Toh YX, Chung KY, Zou G, Lescar J, Lim SP, Shi P-Y. 2010. Biochemical and genetic characterization of dengue virus methyltransferase. Virology 405:568-578.
57. Li S-H, Dong H, Li X-F, Xie X, Zhao H, Deng Y-Q, Wang X-Y, Ye Q, Zhu S-Y, Wang H-J, Zhang B, Leng Q-B, Zuest R, Qin E-D, Qin C-F, Shi P-Y. 2013. Rational design of a flavivirus vaccine through abolishing viral RNA 2=-O methylation. J. Virol. 87:5812-5819.
58. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Jr, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat. Med. 19:458-464. Ifit2 Restricts West Nile Virus Infection